| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
The Pennant Group, Inc. Common Stock$33.5
-1.09 (-3.14%)
Market Cap
1.06 B
EPS
0.86
P/E Ratio
36.64 $
Value Trade
11.81 M
SEC Financials
Q1 2026Dilution Risk
Revenue
285.36 M
Operating CF
-3.40 M
Total Assets
956.48 M
Total Liabilities
567.05 M
Equity
389.44 M
D/E Ratio
12,345
%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
4.91 M
Monthly Burn
1.14 M
Runway
2.9 mo
Burn Trend
SEC Filing
May 6, 2026
Overview
Volume
179.43 K
52 Week Range
21.73 - 35
% held by Insiders
5.01 %
% held by Institutions
91.51 %
Enterprise Value
1.55 B
Total Shares
34.59 M
Short %
1.82 %
Float Shares
32.90 M
Company Description
locked
Upcoming Catalyst
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in PNTG
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
The Pennant Group, Inc. Common Stock (PNTG) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
PNTG
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
PNTG
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
PNTG
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
PNTG Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
PNTG Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-06-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-06-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-06-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-PNTG
Jun 4, 2026The Pennant Group and Hartford HealthCare Expand Collaboration to Advance Home-Based Care in Connecticut
The Pennant Group and Hartford HealthCare have expanded their collaboration to enhance home-based care services in Connecticut. This partnership aims to create a nationally recognized model of home care, focusing on improved clinical outcomes and patient access. The collaboration has already led to a 4-star CMS rating for Hartford HealthCare at Home and plans for further investments in home-based care.
Read more →-PNTG
Jun 3, 2026Pennant Expands Senior Living Presence with Pleasant Hill, California Community
The Pennant Group, Inc. has assumed operations of Memory Care of Contra Costa, a 46-unit memory care community in Pleasant Hill, California. This acquisition marks Pennant's first expansion into California since becoming independent in 2019. The company aims to maintain high-quality care and support for residents and staff during the transition.
Read more →-PNTG
May 18, 2026Pennant Group to Participate in the 2026 RBC Global Healthcare Conference
The Pennant Group, Inc. will participate in the 2026 RBC Global Healthcare Conference on May 20, 2026. Key executives, including the President and CFO, will engage in a fireside chat. The event aims to highlight the company's healthcare services and initiatives. A live webcast will be available for interested audiences.
Read more →-PNTG
May 18, 2026Pennant Announces an Acquisition of Senior Living Community in Arizona
The Pennant Group, Inc. has announced the acquisition of Copper Canyon Memory Care in Tucson, Arizona, expanding its operations by 40 units. CEO Brent Guerisoli emphasized the strategic nature of this acquisition, which aligns with their disciplined capital deployment approach. The acquisition aims to enhance operational efficiency and improve resident outcomes in the Tucson community.
Read more →-PNTG
May 4, 2026Pennant Announces First Quarter 2026 Earnings Release and Call
The Pennant Group, Inc. (NASDAQ: PNTG) announced it will release its first quarter 2026 financial results on May 6, 2026. A live webcast is scheduled for May 7, 2026, where management will discuss these results. This event aims to engage current and prospective investors with detailed financial insights.
Read more →-PNTG
May 1, 2026Pennant Acquires Senior Living Communities in Arizona and Wisconsin
The Pennant Group, Inc. has expanded its operations by acquiring three senior living communities in Arizona and Wisconsin, totaling 194 units. The communities will operate under new names, reflecting Pennant's commitment to quality care. CEO Brent Guerisoli emphasized the importance of disciplined growth and operational excellence in these transactions.
Read more →-PNTG
Apr 1, 2026Pennant Acquires Arbor Rose Senior Living Community in Mesa, Arizona
The Pennant Group, Inc. has acquired Arbor Rose Senior Living in Mesa, Arizona, rebranding it as Lavender Lane Senior Living. This facility offers independent living, assisted living, and memory care services. The acquisition enhances Pennant's portfolio in the East Valley, reflecting its commitment to growth and quality care for seniors.
Read more →Competitive Position
How PNTG ranks across every disease it competes inCompetitive Position is a premium feature
See how PNTG ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial